Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase.
Montazeri G, Rahban M, Mohamadnejad M, Zamani F, Hooshyar A, Fazlolahi A, Abedian S, Ghoujeghi F, Estakhri A, Montazeri F, Razjoyan H, Mamarabadi M, Alimohamadi M, Tavangar SM, Malekzadeh R.
Arch Iran Med. 2010;13(3):193-202.
-Seroprevalence of hepatitis C virus: the first population-based study from Iran.
Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S.
Int J Infect Dis. 2010 Mar 31.
-Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load.
Shahzamani K, Merat S, Rezvan H, Mirab-Samiee S, Khademi H, Malekzadeh R, Sabahi F.
Clin Chem Lab Med. 2010 Jun;48(6):777-84.
-Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study.
Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.
Arch Iran Med. 2010;13(2):99-104.
-Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.
Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A.
Vaccine. 2010 Jan 8;28(3):623-31. Epub 2009 Nov 1. Review. -The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in iran: a population-based study.
Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R.
Arch Iran Med. 2009 May;12(3):225-31.
-Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.
Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R.
J Viral Hepat. 2008 Oct;15(10):753-60. Epub 2008 May 27.
- Interferon resistance of hepatitis C virus genotypes 1a/1b: relationship to structural E2 gene quasispecies mutations
Maryam Honardoost, Farzaneh Sabahi, Samad Amini-Bavil-Olyaee, Farida Behzadian, Shahin Merat, Reza Malekzadeh
Iranian Journal of Biotechnology (IJB), Vol 6, No 1, (2008)
-Hepatitis C seroprevalence among intravenous drug users in Tehran
Mohammad Mahdi Mir-Nasseri, Hossein Poustchi, Siavosh Nasseri-Moghadam, Hamid Tavakkoli, Ashraf Mohammadkhani, Parviz Afshar, Reza Malekzadeh
Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.
J Hepatol. 2008 Jan;48(1):28-34. Epub 2007 Oct 1.
-A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency.
Montazeri F, Montazeri G, Bedayat A, Sedighi N.
Ann Hematol. 2008 Apr;87(4):333-5. Epub 2007 Oct 17. No abstract available
-Persistent alanine aminotransferase elevation among the general Iranian population: Prevalence and causes.
Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Abolghasemi H, Amini S, Maghsoudlu M, Deyhim MR, Rezvan H, Pourshams A.
World J Gastroenterol. 2008 May 14;14(18):2867-71.
-Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis.
Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H.
World J Gastroenterol. 2007 Jun 28;133(24):3359-63.
-Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up.
Fazel I, Pourshams A, Merat S, Hemayati R, Sotoudeh M, Malekzadeh R.
J Gastrointest Surg. 2007 Aug;111(8):1033-8.
-Stem cell therapy in Iran.
Massarrat S.
Arch Iran Med. 2007 Oct;10(4):435-8. No abstract available.
-Phase 1 trial of rial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R.
Arch Iran Med. 2007 Oct;100(4):459-66.
- Current treatment of chronic hepatitis B.
Montazeri G.
Arch Iranian Med 2006; 9 (1): 1 – 10.
- Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone.
Kabir A, Alavian SM, Ahanchi N, Malekzadeh R.
Hepatol Res. 2006 Dec; 36(4):265-71. Epub 2006 Sep 11.
- Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R.
Am J Gastroenterol. 2006 Nov; 101(11):2537-45. Epub 2006 Oct 4.
-Hereditary hemochromatosis: a rare disease in Iran.
Nobakht H, Merat S, Malekzadeh R.
Arch Iran Med. 2006 Jan; 9(1):78-80.
Arch Iranian Med 2006; 9 (1): 1 – 10.
-Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
Mohamadnejad M, Malekzadeh R, Nasseri-Moghaddam S, Hagh-Azali S, Rakhshani N, Tavangar SM, Sedaghat M, Alimohamadi SM.
Dig Dis Sci. 2005 Mar; 50(3):547-51.
-Therapeutic efficacy of an angiotensin ii receptor antagonist in patients with Nonalcoholic Steatohepatitis
S. Merat, R. Malekzadeh.
Arch Iran Med 2005, Volume 8, Number 2.
- Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.
Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani A, Derakhshan MH, Zamani F, Samiee S, Malekzadeh R. BMC Gastroenterol. 2005 Oct 12; 5:32.
- Efficacy of Hepatitis B Virus Surface Antigen Vaccine as a Therapeutic Tool, in Inactive Hepatitis B Virus Carriers.
Montazeri Gh, Farzadi Z, Fazllolahi A, Abedian Sh, Montazeri F, Estakhri A, Noori N, Malekzadeh R.
Govaresh journal / Vol. 10, No. 4, Winter 2005; 227-232.
- A Comparison between Pegylated Interferon Alpha-2a and Standard Interferon in Combination with Ribavirin in Treating Patients with Bleeding Disorders and Chronic Hepatitis C.
Merat Sh, Sohrabpour AA, Khaleghi S, Sohrabi MR, Samimi-Rad K, Radmard AR, Mousavian A, Keyvani H, Rezvan H, Malekzadeh R.
Govaresh journal, Vol. 10, No. 2, Summer 2005; 108-115.
- HCV in Intravenous Drug Users.
Mir-Nasseri MM, Poustchi H, Nasseri-Moghadam S, Nouraie SM, Tahaghoghi S, Afshar P, Mohammadkhani A, Tavakoli H, Malekzadeh R.
Govaresh journal, Volume 10, Number 2, Summer 2005, 80-86.
- Interferon Monotherapy in Major Thalassemic Patients with Hepatitis C Infection.
Farhad Zamani, Ramin Shakeri, Masoomeh Islam, Hassan Taheri, Mehdi Mohamadnejad, Reza Malekzadeh.
Govaresh journal, Vol. 10, No. 3, Autumn 2005; 178-182.
-Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region.
Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L.
J Med Virol. 2004 Oct; 74(2):246-52
- Reversibility of cirrhosis in autoimmune hepatitis.
Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, Rakhshani N, Tavangar SM, Sohrabpour AA, Tahaghoghi S.
Am J Med. 2004 Jul 15; 117(2):125-9. No abstract available.
- Hepatitis B.
Mohamadnejad M, Malekzadeh R.
N Engl J Med. 2004 Jun 24; 350(26):2719-20. No abstract available.
- Reversibility of cirrhosis in chronic hepatitis B.
Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, Tavangar SM, Sohrabpour AA.
Clin Gastroenterol Hepatol. 2004 Apr; 2(4):344-7.
- Hepatitis C in Hemophiliac Patients.
Alavian SM, Hajarizadeh B, Malekzadeh R.
Govaresh journal, Volume 8, Number. 4, Winter 2003.
- Passive and Active Immunization in Prevention of Vertical Transmission of HBV Infection in Infants of HBsAg Positive Mothers.
Malekzadeh R, Alavian SM, Kabir A, Ahanchi N.
Govaresh journal, Volume 9, Number 3, Autumn 2004, 181-187.
-Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors.
Alavian SM, MoMalekzadeh stajabi P, R, Azimi K, Vosough H, Sarrafi M, Daneshfar B, Riyazi Sh,Ahmadzad Asl M.
Govaresh journal, Volume 9, Number 3, Autumn 2004, 169-175.
-Treatment algorithm for the management of chronic hepatitis b virus infection in the United States. M. Mohammadnejad, R. Malekzadeh, S. Rad.
Arch Iran Med 2004, Volume 7, Number 4
- Screening for hepatitis C virus infection: a review of the evidence for the U.S. preventive services task Force. S. Nasseri-Moghaddam, R. Malekzadeh.
Arch Iran Med, April 2004, Volume 7, Number 2
-Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study.
Merat S, Malekzadeh R, Sohrabi MR, Sotoudeh M, Rakhshani N, Sohrabpour AA, Naserimoghadam S.
J Hepatol. 2003 Apr; 38(4):414-8.
-Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study.
Merat S, Malekzadeh R, Sohrabi MR, Hormazdi M, Naserimoghadam S, Mikaeli J, Farahvash MJ, Ansari R, Sotoudehmanesh R, Khatibian M.
J Clin Gastroenterol. 2003 Mar; 36(3):266-8.
-Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.
Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M.
Dig Dis Sci. 2001 Jun; 46(6):1321-7. - Hepatitis B in Iran
Meraat Sh, Malekzadeh R, Rezvan H, Khatibian M.
Arch Iran Med Volume 3, Number 4 Oct. 2
